Condition: Ulcerative Colitis · Ulcerative Colitis Chronic Mild · Ulcerative Colitis Chronic Moderate · Sponsor: Wolfson Medical Center
The ReDUCE Trial is a multinational single-blinded randomized controlled trial in mild to moderate flare of Ulcerative colitis (UC) disease patients. The purpose of the study is to validate the clinical efficacy of the UCED (Ulcerative colitis Exclusion Diet) with partial enteral nutrition (PEN) using a novel formula. The investigators anticipate that adding a novel specifically designed dietary intervention in addition to drug will lead to superior remission and mucosal healing via changes in the microbiome.
This description comes directly from the study's public registry record.
Contact details are listed per location below or on the registry record.
Always discuss trial participation with your own doctor first.
| Emek Medical Center | Afula, Israel | Not Yet Recruiting |
| Wolfson Medical Center | Holon, Israel | Recruiting |
| Tel Aviv Sourasky Medical Center | Tel Aviv, Israel | Recruiting |
| FONDAZIONE GEMELLI HOSPITAL Catholic University of the Sacred Hearth | Roma, Italy | Not Yet Recruiting |
| Radboud University Medical Center (Radboudumc) | Nijmegen, Netherlands | Not Yet Recruiting |
| Kantonsspital St. Gallen | Sankt Gallen, Switzerland | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05791487